Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00798460

Recruitment Status : Terminated (could not enroll patients)

First Posted : November 26, 2008

Last Update Posted : June 23, 2011

Sponsor:

Collaborator:

Bukwang Pharmaceutical

Information provided by:

Inje University

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	June 2010
Actual Study Completion Date :	November 2010

To Top